Previous Nav
Net Change on 19-01-2021
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Cipla Limited
Dr. Reddy's Laboratories Limited
IPCA Laboratories Limited
Lupin Limited
Divi's Laboratories Limited
Procter & Gamble Health Limited
TREPS / Reverse Repo Investments / Corporate Debt Repo
Sun Pharmaceutical Industries Limited
Apollo Hospitals Enterprise Limited
Torrent Pharmaceuticals Limited
Max Healthcare Institute Limited
Intuitive Surgical Inc
ICICI Lombard General Insurance Company Limited
JB Chemicals & Pharmaceuticals Limited
Abiomed Inc
Dr. Lal Path Labs Ltd.
Syngene International Limited
Narayana Hrudayalaya Ltd.
Alkem Laboratories Limited
Indoco Remedies Limited
Abbott Laboratories
Alembic Pharmaceuticals Limited
Aarti Drugs Limited
Unichem Laboratories Limited
Abbott India Limited
Ajanta Pharma Limited
Net Receivables/Payables
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Insurance
Cash
Equity
DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹1,043.27 crore. DSP Healthcare Fund is benchmarked against S&P BSE Health Care as primary index.
The NAV of DSP Healthcare Fund ended up ₹0.24(1.25%)yesterday to ₹19.538.
Among its top 3 holdings the fund has exposure to Cipla Limited, and
The DSP Healthcare Fund is managed by Vinit Sambre and Jay Kothari.
Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021